잠시만 기다려 주세요. 로딩중입니다.

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Clinical and Molecular Hepatology 2020년 26권 4호 p.411 ~ 429
임형준, 김지훈, 박준용, Yoon Eileen L., Park Ha-Na, 권정현, 신동현, 이세환, 이정훈, 이현웅,
소속 상세정보
임형준 ( Yim Hyung-Joon ) - Korea University College of Medicine Department of Internal Medicine
김지훈 ( Kim Ji-Hoon ) - Korea University College of Medicine Department of Internal Medicine
박준용 ( Park Jun-Yong ) - Yonsei University College of Medicine Department of Internal Medicine
 ( Yoon Eileen L. ) - Inje University College of Medicine Department of Internal Medicine
 ( Park Ha-Na ) - Asan Medical Center Department of Health Medicine
권정현 ( Kwon Jung-Hyun ) - Catholic University College of Medicine Department of Internal Medicine
신동현 ( Sinn Dong-Hyun ) - Sungkyunkwan University School of Medicine Department of Internal Medicine
이세환 ( Lee Sae-Hwan ) - Soonchunhyang University College of Medicine Department of Internal Medicine
이정훈 ( Lee Jeong-Hoon ) - Seoul National University College of Medicine Department of Internal Medicine
이현웅 ( Lee Hyun-Woong ) - Yonsei University College of Medicine Department of Internal Medicine

Abstract


Clinical practice guidelines are important for guiding the management of specific diseases by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as a reference for health policymakers in controlling diseases with a large public impact. With this in mind, practice guidelines for the management of chronic hepatitis B (CHB) have been developed in the United States, Europe, and Asian-Pacific regions to suggest the best-fit recommendations for each social and medical circumstance. Recently, the Korean Association for the Study of the Liver published a revised version of its clinical practice guidelines for the management of CHB. The guidelines included updated information based on newly available antiviral agents, the most recent opinion on the initiation and cessation of treatment, and updates for the management of drug resistance, partial virological response, and side effects. Additionally, CHB management in specific situations was comprehensively revised. This review compares the similarities and differences among the various practice guidelines to identify unmet needs and improve future recommendations.

키워드

Hepatitis B, Chronic; Hepatitis B virus; Clinical practice guidelines

원문 및 링크아웃 정보

등재저널 정보